Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines

https://doi.org/10.1016/j.bmcl.2007.07.027Get rights and content

Abstract

In continuation of our earlier work on benzothiadiazines, we have prepared a series of nitrofuran, nitrothiophene and arylfuran coupled benzothiadiazines and evaluated them for antimycobacterial and antibacterial activities. One of the compounds 2f has shown good in vitro antimycobacterial activity. All the synthesized compounds have shown moderate to good antibacterial activity.

Section snippets

Acknowledgment

The authors S.K.A., K.S.R., M.N.A.K. and R.V.C.R.N.C.S. thank CSIR, New Delhi, for the award of research fellowships.

References and notes (26)

  • B. Murugasu-Oei et al.

    J. Antimicrob. Chemother.

    (2000)
  • A. Baliani et al.

    J. Med. Chem.

    (2005)
    M.L. Stewart et al.

    Antimicrob. Agents Chemother.

    (2004)
    G. Aguirre et al.

    Eur. J. Med. Chem.

    (2004)
    N. Bharti et al.

    Bioorg. Med. Chem. Lett.

    (2002)
    H. Cerecetto et al.

    Il Farmaco

    (1998)
  • R. Millet et al.

    J. Med. Chem.

    (2005)
  • S. Lee et al.

    Bioorg. Med. Chem. Lett.

    (2007)
    S. Lee et al.

    J. Med. Chem.

    (2005)
  • P. De Tullio et al.

    J. Med. Chem

    (2006)
  • M. Di Bella et al.

    Farmaco [Sci.]

    (1983)
    M. Di Bella et al.

    Farmaco [Sci.]

    (1979)
  • A. Kamal et al.

    Bioorg. Med. Chem.

    (2006)
  • A.V.N. Reddy et al.

    Indian J. Chem.

    (1985)
  • M. Kumar et al.

    Diag. Microbiol. Infect. Dis

    (2005)
  • D.E. Snider et al.C. Dye et al.

    J. Am. Med. Assoc.

    (1999)
  • A. Pozniak

    Ann. N.Y. Acad. Sci.

    (2001)
  • Cited by (31)

    • Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents

      2019, Bioorganic Chemistry
      Citation Excerpt :

      This will offer the opportunity to study the effects of changes in steric, electronic and hydrophobic properties of substituents on the anti-TB activity of these 5-nitrofuran-based carbothioamides, as well as the introduction of functional groups allowing drug-target interactions that may promote the activity and lessen cytotoxicity. Anti-TB activity profiles of nitrofuran coupled benzothiadiazines 3 and 4 (Fig. 4) were reported by Kamal et al. [35]. Compounds 3a-g (MIC = 1–16 µg/mL) were more potent than compounds 4a-d (MIC = 4–32 µg/mL).

    View all citing articles on Scopus
    View full text